2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers Contributing to the Growth and Expansion of the Acute Lung Injury Market?
The escalation in respiratory ailments is predicted to amplify the expansion of the acute lung injury market in the future. Respiratory ailments are a collection of disorders impacting the lungs and other parts of the respiratory system, resulting in troubled breathing and defective lung function. The escalation in respiratory disorders can be credited to the augmentation of air contamination, smoking, inactive lifestyles, aging populations, and the influence of viral contagions. Respiratory disorders, such as pneumonia, trigger acute lung injury by instigating severe inflammation and damaging the alveoli, resulting in compromised gas exchange and respiratory distress. For instance, the Australian Bureau of Statistics, an Australian government agency, reported in September 2023 that the death rate from influenza and pneumonia in the country climbed from 31.9 per 100,000 people in 2021 to 42.6 per 100,000 people in 2022, marking a significant rise of roughly 33.54%. Consequently, the escalation of respiratory ailments is fueling the growth of the acute lung injury market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20704&type=smp
How Has the Acute Lung Injury Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?
In recent times, the market size of acute lung injury has been witnessing consistent growth. It is predicted to expand from $2.48 billion in 2024 to $2.60 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 4.7%. The expansion during the historical period can be credited to factors such as heightened awareness campaigns, rise in ICU admissions, smoke and air pollution, infections acquired in hospitals, and initiatives to reduce the mortality rate.
The market size for acute lung injury is projected to grow consistently in the coming years, escalating to $3.09 billion in 2029 with a compound annual growth rate (CAGR) of 4.4%. This growth in the estimated time span can be credited to advancements in biologics and gene therapies, government investments and grants, the evolution of precision medication, regenerative medicine and stem cell therapies, as well as reforms in global health policies. The dominating trends in the forecast period will include the production of biologic drugs, adoption of wearable and distance monitoring devices, inhalation-centric therapies, CRISPR and gene-editing technologies, and biosensors for real-time analysis.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20704
What New Market Trends Are Reshaping theAcute Lung Injury Market and Its Opportunities?
Leading companies in the acute lung injury market are concentrating on creating innovative treatments such as peptide treatments to maintain their hold in the market. The term peptide treatment pertains to utilizing short sequences of amino acids (peptides) as therapeutic agents to manage medical ailments. For example, Zuventus Healthcare Ltd, a healthcare firm based in India, introduced Aviptadil in November 2022 to manage acute respiratory distress syndrome (ARDS). This therapy provides numerous distinct advantages such as potent vasodilatory properties which are 50 times more efficient than prostacyclin, a lung defense mechanism that encourages surfactant production by connecting to alveolar type II cells. Additionally, it has anti-inflammatory properties that restrain pro-inflammatory cytokines such as IL-6 and TNF-alpha, and imparts immunomodulatory action to control immune reactions in the lungs. Clinically, Aviptadil has demonstrated its efficacy in improving the prognosis for patients suffering from severe virus-associated ARDS.
Who Are the Leading Market Players Fueling Growth in the Acute Lung Injury Market Trend?
Major companies operating in the acute lung injury market are Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Medtronic plc, Baxter International Inc., Ono Pharmaceutical Co Ltd., Aster DM Healthcare, Octapharma AG, Cartesian Therapeutics Inc., Vapotherm Inc., Stemedica Cell Technologies Inc., Implicit Bioscience Ltd., Apeiron Biologics AG, Faron Pharmaceuticals Ltd., Histocell Sociedad Limitada, Vasomune Therapeutics Inc, Windtree Therapeutics Inc., Qx Therapeutics Inc., Asklepion Pharmaceuticals LLC, ReAlta Life Sciences Inc., MediciNova Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/acute-lung-injury-global-market-report
How is the Global Acute Lung Injury Market Segemented?
The acute lung injury market covered in this report is segmented –
1) By Injury Type: Direct Injury, Indirect Injury
2) By Therapy: Mechanical Ventilation, Pharmacotherapy, Fluid Management, Other Therapies
3) By End User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Direct Injury: Trauma-Induced Acute Lung Injury, Aspiration Pneumonitis, Pneumonia-Related Acute Lung Injury, Inhalation Injury
2) By Indirect Injury: Sepsis-Related Acute Lung Injury, Shock-Induced Acute Lung Injury, Acute Lung Injury Due To Blood Transfusion, Acute Lung Injury Associated With Pancreatitis
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20704&type=smp
Which Geographics are Influencing the Growth of the Acute Lung Injury Market?
North America was the largest region in the acute lung injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute lung injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Acute Lung Injury Market 2025, By The Business Research Company:
Lung Cancer Drugs Global Market Report 2025
https://thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report
Lung Cancer Diagnostic And Screening Global Market Report 2025
Small Cell Lung Cancer Therapeutics Global Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: